Abstract
Convergent findings indicate that cannabis use and variation in the cannabinoid CB1 receptor coding gene (CNR1) modulate prefrontal function during working memory (WM). Other results also suggest that cannabis modifies the physiological relationship between genetically induced expression of CNR1 and prefrontal WM processing. However, it is possible that cannabis exerts its modifying effect on prefrontal physiology by interacting with complex molecular ensembles co-regulated with CB1. Since co-regulated genes are likely co-expressed, we investigated how genetically predicted co-expression of a molecular network including CNR1 interacts with cannabis use in modulating WM processing in humans. Using post-mortem human prefrontal data, we first computed a polygenic score (CNR1-PCI), combining the effects of single nucleotide polymorphisms (SNPs) on co-expression of a cohesive gene set including CNR1, and positively correlated with such co-expression. Then, in an in vivo study, we computed CNR1-PCI in 88 cannabis users and 147 non-users and investigated its interaction with cannabis use on brain activity during WM. Results revealed an interaction between cannabis use and CNR1-PCI in the dorsolateral prefrontal cortex (DLPFC), with a positive relationship between CNR1-PCI and DLPFC activity in cannabis users and a negative relationship in non-users. Furthermore, DLPFC activity in cannabis users was positively correlated with the frequency of cannabis use. Taken together, our results suggest that co-expression of a CNR1-related network predicts WM-related prefrontal activation as a function of cannabis use. Furthermore, they offer novel insights into the biological mechanisms associated with the use of cannabis.
Similar content being viewed by others
References
Ashburner, J., & Friston, K. J. (1999). Nonlinear spatial normalization using basis functions. Human brain Mapping, 7(4), 254–266.
Barkus, E. J., Stirling, J., Hopkins, R. S., & Lewis, S. (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology, 39(4), 175–178.
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar-Poli, P., Crippa, J. A., et al. (2013). Structural and functional imaging studies in chronic Cannabis users: A systematic review of adolescent and adult findings. PLoS One, 8(2), e55821.
Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., Irving, A. J., Katona, I., Yanagawa, Y., Rakic, P., Lutz, B., Mackie, K., & Harkany, T. (2007). Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science., 316(5828), 1212–1216.
Bertolino A., Blasi G. (2009) The genetics of schizophrenia. Neuroscience 164 (1):288-299
Blasi, G., De Virgilio, C., Papazacharias, A., Taurisano, P., Gelao, B., Fazio, L., Ursini, G., Sinibaldi, L., Andriola, I., Masellis, R., Romano, R., Rampino, A., Di Giorgio, A., Lo Bianco, L., Caforio, G., Piva, F., Popolizio, T., Bellantuono, C., Todarello, O., Kleinman, J. E., Gadaleta, G., Weinberger, D. R., & Bertolino, A. (2013). Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment. JAMA Psychiatry., 70(9), 921–930.
Bossong, M. G., Jager, G., van Hell, H. H., Zuurman, L., Jansma, J. M., Mehta, M. A., van Gerven, J. M., Kahn, R. S., & Ramsey, N. F. (2012). Effects of Delta9-tetrahydrocannabinol administration on human encoding and recall memory function: A pharmacological FMRI study. Journal of Cognitive Neuroscience, 24, 588–599.
Callicott, J. H., Bertolino, A., Mattay, V. S., Langheim, F. J., Duyn, J., Coppola, R., Goldberg, T. E., & Weinberger, D. R. (2000). Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex., 10(11), 1078–1092.
Callicott, J. H., Egan, M. F., Mattay, V. S., Bertolino, A., Bone, A. D., Verchinksi, B., & Weinberger, D. R. (2003). Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry, 160(4), 709–719.
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R., & Craig, I. W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57(10), 1117–1127.
Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., Colantuoni, E. A., Elkahloun, A. G., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature, 478(7370), 519–523.
Colizzi, M., Fazio, L., Ferranti, L., Porcelli, A., Masellis, R., Marvulli, D., Bonvino, A., Ursini, G., Blasi, G., & Bertolino, A. (2015). Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology, 40(3), 640–649.
Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013). Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences, and sex differences. Neuropsychology Review, 23(2), 117–137.
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S. A., Wiffen, B., Powell, J., & Murray, R. M. (2009). High-potency cannabis and the risk of psychosis. British Journal of Psychiatry, 195(6), 488–491.
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Science of the USA, 95(25), 14863–14868.
Fazio, L., Pergola, G., Papalino, M., Di Carlo, P., Monda, A., Gelao, B., Amoroso, N., Tangaro, S., Rampino, A., Popolizio, T., Bertolino, A., & Blasi, G. (2018). Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proceedings of the National Academy of Sciences of the United States of America, 115(21), 5582–5587.
First, M. B., Gibbon, M., Spitzer, R. L., & Williams, J. B. W. (1996). Guide for the structured clinical interview for DSM-IV Axis I disorders-research version. New York: Biometrics Research.
Friston, K. J., Williams, S., Howard, R., Frackowiak, R. S., & Turner, R. (1996). Movement-related effects in fMRI time-series. Magnetic Resonance in Medicine, 35(3), 346–355.
Fromer, M., Roussos, P., Sieberts, S. K., Johnson, J. S., Kavanagh, D. H., Perumal, T. M., Ruderfer, D. M., Oh, E. C., Topol, A., Shah, H. R., Klei, L. L., Kramer, R., Pinto, D., Gümüş, Z. H., Cicek, A. E., Dang, K. K., Browne, A., Lu, C., Xie, L., Readhead, B., Stahl, E. A., Xiao, J., Parvizi, M., Hamamsy, T., Fullard, J. F., Wang, Y. C., Mahajan, M. C., Derry, J. M., Dudley, J. T., Hemby, S. E., Logsdon, B. A., Talbot, K., Raj, T., Bennett, D. A., De Jager, P. L., Zhu, J., Zhang, B., Sullivan, P. F., Chess, A., Purcell, S. M., Shinobu, L. A., Mangravite, L. M., Toyoshiba, H., Gur, R. E., Hahn, C. G., Lewis, D. A., Haroutunian, V., Peters, M. A., Lipska, B. K., Buxbaum, J. D., Schadt, E. E., Hirai, K., Roeder, K., Brennand, K. J., Katsanis, N., Domenici, E., Devlin, B., & Sklar, P. (2016). Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nature Neuroscience, 19(11), 1442–1453.
Fukuda, T., Nagashima, S., Abe, T., Kiyonari, H., Inatome, R., & Yanagi, S. (2016). Rescue of CAMDI deletion-induced delayed radial migration and psychiatric behaviors by HDAC6 inhibitor. EMBO reports, 17(12), 1785–1798.
Gaiteri, C., Ding, Y., French, B., Tseng, G. C., & Sibille, E. (2014). Beyond modules and hubs: The potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain and Behavior, 13(1), 13–24.
Ganzer, F., Br Ning, S., Kraft, S., Sack, P.-M., & Thomasius, R. (2016). Weighing the evidence: A systematic review on long-term neurocognitive effects of cannabis use in abstinent adolescents and adults. Neuropsychology Review, 26(2), 186–222.
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent 3rd, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., Rapoport, J. L., & Thompson, P. M. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America, 101(21), 8174–8179.
Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience, 11(2), 563–583.
Jacobus, J., & Tapert, S. F. (2014). Effects of cannabis on the adolescent brain. Current Pharmaceutical Design, 20(13), 2186–2193.
Koleske, A. J. (2013). Molecular mechanisms of dendrite stability. Nature Reviews Neuroscience, 14(8), 536–550.
Lancichinetti, A., & Fortunato, S. (2012). Consensus clustering in complex networks. Scientific Reports, 2, 2012.
Lisdahl, K. M., & Price, J. S. (2012). Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults. Journal of the International Neuropsychological Society, 18(4), 678–688. https://doi.org/10.1017/S1355617712000276.
Lisdahl, K. M., Wright, N. E., Kirchner-Medina, C., Maple, K. E., & Shollenbarger, S. (2014). Considering cannabis: The effects of regular cannabis use on neurocognition in adolescents and young adults. Current Addiction Reports, 1(2), 144–156.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015). Cannabis and adolescent brain development. Pharmacology & Therapeutics, 148, 1–16.
Monaco, A., Monda, A., Amoroso, N., Bertolino, A., Blasi, G., Di Carlo, P., Papalino, M., Pergola, G., Tangaro, S., & Bellotti, R. (2018). A complex network approach reveals a pivotal substructure of genes linked to schizophrenia. PLoS One, 13(1), e0190110.
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America, 109(40), E2657–E2664.
Meier, M. H., Caspi, A., Danese, A., Fisher, H. L., Houts, R., Arseneault, L., & Moffitt, T. E. (2018). Associations between adolescent cannabis use and neuropsychological decline: A longitudinal co-twin control study. Addiction, 113(2), 257–265.
Monda A, Amoroso N, Altomare Basile TM, Bellotti R, Bertolino A, Blasi G, Di Carlo P, Fanizzi A, La Rocca M, Maggipinto T, Monaco A, Papalino M, Pergola G, Tangaro S (2017) Topological complex networks properties for Gene Community detection strategy: DRD2 case study. Emergent Complexity from Nonlinearity, in Physics, Engineering and the Life Sciences. Springer, Cham, pp.199–208.
Oldfield, R. C. (1971). The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia, 9(1), 97–113.
Pergola, G., Di Carlo, P., Andriola, I., Gelao, B., Torretta, S., Attrotto, M. T., Fazio, L., Raio, A., Albergo, D., Masellis, R., Rampino, A., Blasi, G., & Bertolino, A. (2016). Combined effect of genetic variants in the GluN2B coding gene (GRIN2B) on prefrontal function during working memory performance. Psychological Medicine, 46(6), 1135–1150.
Pergola, G., Di Carlo, P., D'Ambrosio, E., Gelao, B., Fazio, L., Papalino, M., Monda, A., Scozia, G., Pietrangelo, B., Attrotto, M., Apud, J. A., Chen, Q., Mattay, V. S., Rampino, A., Caforio, G., Weinberger, D. R., Blasi, G., & Bertolino, A. (2017). DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia. Translational Psychiatry, 7(1), e1006.
Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215.
SalthouseTA, A. T. M., & Berish, D. E. (2003). Executive functioning as a potential mediator of age-related cognitive decline in normal adults. Journal of Experimental Psychology: General, 132(4), 566–594.
Schwarz Gideon, E. (1978). Estimating the dimension of a model. Annals of Statistics, 6(2), 461–464.
Snodgrass, J. G., & Corwin, J. (1988). Pragmatics of measuring recognition memory: Applications to dementia and amnesia. Journal of Experimental Psychology: General, 117, 34–50.
Sobell, L. C., Agrawal, S., Annis, H., Ayala-Velazquez, H., Echeverria, L., Leo, G. I., et al. (2001). Cross-cultural evaluation of two drinking assessment instruments: Alcohol timeline followback and inventory of drinking situations. Substance Use & Misuse, 36(3), 313–331.
Sobell, L. C., Agrawal, S., Sobell, M. B., Leo, G. I., Young, L. J., Cunningham, J. A., & Simco, E. R. (2003). Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems. Journal of Studies on Alcohol, 64(6), 858–861.
Taurisano, P., Antonucci, L. A., Fazio, L., Rampino, A., Romano, R., Porcelli, A., Masellis, R., Colizzi, M., Quarto, T., Torretta, S., Di Giorgio, A., Pergola, G., Bertolino, A., & Blasi, G. (2016). Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use. Cortex, 81, 231–238.
van Os, J., Kenis, G., & Rutten, B. P. (2010). The environment and schizophrenia. Nature., 468(7321), 203–212.
Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brasic, J., Guevara, M., Ye, W., Dannals, R. F., Ravert, H. T., Nandi, A., Rahmim, A., Ming, J. E., Grachev, I., Roy, C., & Cascella, N. (2010). Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR. Neuroimage, 52(4), 1505–1513.
Zhang B, Horvath S (2005). A general framework for weighted gene co-expression network analysis. Statistical Applications in General and Molecular Biology 4: Article17.
Zoghbi, H. Y. (2003). Postnatal neurodevelopmental disorders: Meeting at the synapse? Science., 302(5646), 826–830.
Acknowledgments
We are grateful to Dr. Grazia Caforio, Dr. Marco Colizzi, Dr. Leonardo Fazio, Dr. Barbara Gelao and Dr. Tiziana Quarto, for making data acquisition possible and for the fruitful discussion on the topic of this work. Moreover, we would like to acknowledge all people who participated in this study.
Funding
This research has been partly funded by the “Capitale Umano ad Alta Qualificazione” grant by Fondazione Con Il Sud (2011-PDR-06), by a NARSAD grant (28935), by a Ricerca Finalizzata grant (PE-2011-02347951) awarded to Alessandro Bertolino, and by a Hoffmann-La Roche collaboration grant titled “Gene co-expression networks as roadmap for genotype to phenotype mapping in schizophrenia” awarded to Giulio Pergola. Giulio Pergola’s position is funded by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant (No. 798181). This article reflects only the authors’ views, and the European Union and Research Executive Agency are not liable for any use that may be made of the information contained therein.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in this study involving human participants have been approved by the University of Bari ethic committee and comply with the 1964 Helsinki declaration, its later amendments and comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Conflict of interest
Giuseppe Blasi received lecture fees from Jannsen and Lundbeck. Alessandro Bertolino is a stockholder of Hoffmann-La Roche Ltd. He has also received consulting fees from Biogen and lecture fees from Otsuka, Janssen, Lundbeck. Giulio Pergola has been the academic supervisor of a Roche collaboration grant (years 2015–16) that funded his and Antonio Rampino’s salary. Antonio Rampino has received travel fees from Lundbeck. All other authors have no biomedical financial interests and no potential conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 118 kb)
Rights and permissions
About this article
Cite this article
Taurisano, P., Pergola, G., Monda, A. et al. The interaction between cannabis use and a CB1-related polygenic co-expression index modulates dorsolateral prefrontal activity during working memory processing. Brain Imaging and Behavior 15, 288–299 (2021). https://doi.org/10.1007/s11682-020-00256-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-020-00256-z